Los Angeles General Medical Center, Los Angeles, CA – FDA Inspections

Inspection records and compliance data for Los Angeles General Medical Center in Los Angeles, California. 8 FDA inspections on record, last inspected July 19, 2024.

Company Profile

This profile covers Los Angeles General Medical Center based in Los Angeles, California, United States.

FDA Inspection History

FDA inspections: 8
OAI: 0
VAI: 1
NAI: 7
Form 483s: 0
Warning letters: 0

First inspected January 20, 2009. Last inspected July 19, 2024.

Most cited issue areas

Biological product deviation report1 inspection
Thorough investigations1 inspection

FDA inspections (8)

Date	Result	FDA center(s)	Insp. #
July 19, 2024	NAI	Biologics · Blood and Blood Products	1245241
March 20, 2019	NAI	Biologics · Blood and Blood Products	1085150
June 15, 2017	NAI	Biologics · Blood and Blood Products	1017569
May 7, 2015	NAI	Biologics · Blood and Blood Products	925621
September 12, 2013	NAI	Biologics · Blood and Blood Products	848378
November 23, 2010	NAI	Biologics · Blood and Blood Products	699973
September 30, 2009	VAI	Biologics · Human Cellular, Tissue, and Gene Therapies	615708
January 20, 2009	NAI	Biologics · Human Cellular, Tissue, and Gene Therapies	561249

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Kaiser Foundation Hospital Laboratory West Los Angeles

Stanford Healthcare ValleyCare

Octapharma Plasma Inc

CCRM San Francisco, LLC

California Cryobank LLC

Renaissance Biologic Resources LLC

Richard A. Lewis, M.D.

West Coast Clinical Laboratories, Inc.

Church, Joseph A., M.D.

Huntington Reproductive Center Laboratory